Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

0.275
Delayed Data
As of 3:59pm ET
 -0.012 / -4.18%
Today’s Change
0.21
Today|||52-Week Range
2.97
-83.33%
Year-to-Date
No recent news for Anthera Pharmaceuticals Inc.

Today’s Trading

Previous close0.29
Today’s open0.29
Day’s range0.28 - 0.30
Volume211,874
Average volume (3 months)2,327,442
Market cap$7.4M
Data as of 3:59pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+77.80%
Earnings growth (this year)+20.28%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABIOARCA Biopharma Inc+0.00+0.68%
KZIAKazia Therapeutics L...-0.17-4.80%
OGENOragenics Inc+0.05+3.07%
CBIOCatalyst Biosciences...-0.40-3.71%
Data as of 4:00pm ET, 06/21/2018

Financials

Last reporting dateMay 14, 2018
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$0.00
Annual profit (last year)-$26.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Executive Director
John Craig Thompson
CAO, Senior VP-Finance &
Administration
May Liu
Corporate headquarters
Hayward, California

Forecasts